Clinical Trials Directory

Trials / Completed

CompletedNCT06613828

Efficacy of Five Strategies To Improve Stroke Awareness in the Spanish-Speaking Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
435 (actual)
Sponsor
Instituto Mexicano del Seguro Social · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this experimental study is to evaluate the efficacy of five educational strategies for recognizing early symptoms of cerebrovascular disease (CVD) in the general adult population. The main questions it aims to answer are: \- How effective are the strategies RAPIDO, CORRE, DALE, CAMALEON, and ICTUS 911 in improving the recognition of early CVD symptoms? Researchers will compare these strategies to determine which one leads to the highest increase in symptom recognition. Participants will receive a brief educational session on one of the five strategies and will: * Complete a pre- and post-intervention survey (Stroke Awareness Questionnaire, SAQ). * Receive short training on CVD symptoms and the urgency of contacting emergency services. The primary outcome is the improvement in SAQ scores, and the secondary outcome is the proportion of participants achieving adequate knowledge of CVD symptoms.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMnemonic-Based Educational Training for Stroke Symptom RecognitionThis is a Culturally Adapted Mnemonic-Based Educational Strategies for Rapid Stroke Symptom Recognition in the Spanish-Speaking Population. It uses five distinct mnemonic strategies (RAPIDO, CORRE, DALE, CAMALEON, ICTUS 911), each specifically tailored for a Spanish-speaking audience. Aims to improve the recognition of early cerebrovascular disease symptoms, differentiating it from other clinical studies that might focus on different health conditions or target populations. Emphasizes its focus on rapid action by educating participants about stroke symptoms and the importance of contacting emergency services (911).

Timeline

Start date
2024-04-01
Primary completion
2024-10-20
Completion
2024-11-07
First posted
2024-09-26
Last updated
2025-05-01

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT06613828. Inclusion in this directory is not an endorsement.